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Objective: Primary concerns about currently available pericardial substi-
tutes include adhesion and epicardial reaction. The purpose of this study is
to evaluate host reaction to pericardial substitutes with and without
incorporating slow heparin release. Methods: To avoid biologic variation
among these pericardial patches, we made a composite of six membranes.
The composite membrane consisted of epoxy-fixed patches with (1) or
without (2) ionically bound heparin, a glutaraldehyde-fixed patch with (3)
or without (4) ionically bound heparin, an expanded polytetrafluoroethyl-
ene patch (5), and a polyester polymeric patch (6). Ten recipient dogs
weighing from 12 to 19 kg (mean 13.6 kg) were used to assess the composite
membranes as pericardial substitutes. The implanted composite mem-
branes were retrieved 1 week (one dog), 2 weeks (one dog), 4 weeks (one
dog), 8 weeks (one dog), and 12 weeks (six dogs) after implantation. Results:
Overall, the synthetic patches had a more notable inflammatory reaction
than the biologic patches with or without ionically bound heparin. The
heparin-bound patches caused significantly less inflammation than their
nonheparinized counterparts. The heparinized porcine patches cross-
linked with different compounds were found to have less fibrous formation
than the nonheparinized patches and the synthetic patches. Conclusions:
Heparinized pericardial substitutes may cause less adhesion and inflam-
matory reaction than nonheparinized material. (J Thorac Cardiovasc Surg
1998;115:1111-20)
Primary closure of the pericardium is recom-mended because it is believed to reduce the
formation of mediastinal adhesion and postopera-
tive complications. The use of pericardial substitutes
is advocated when primary closure is not possible.
Several materials can be used as pericardial substi-
tutes, including fascia lata,1 silicone rubber,2-4 rub-
ber-coated Dacron2 or polyester polymer,5 and poly-
tetrafluoroethylene (PTFE),2 as well as mammalian
pericardium.6-11 These materials have been tested in
the past to facilitate reoperations, with inconclusive
results.
The primary concerns about currently available
pericardial substitutes include adhesion and epicar-
dial reaction. The synthetic patches, made from
expanded PTFE (ePTFE) or polyester polymer (Da-
cron), are widely used as pericardial substitutes.
Several groups2-6 reported the presence of a tissue-
free space around the synthetic patch that facilitates
the opening of the chest and diminishes damage to
the heart. However, the synthetic patch brought on
severe inflammatory reaction and diffuse fibrosis.
The epicardium beneath the synthetic patch became
covered by a dense layer of fibrotic tissue. In a
canine model, Meus and associates5 reported that
recognition of the coronary artery was greatly im-
peded by this fibrotic tissue, which was very difficult
to separate from the underlying myocardium and
vessels. The glutaraldehyde-fixed patches, made
from heterologous porcine,5, 6 equine,7, 8 and bovine
pericardium,9-11 were often used as pericardial sub-
stitutes. However, glutaraldehyde tended to stiffen
biologic tissue and enhance fibrosis, adhesion, and
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calcification.11 To address the aforementioned defi-
ciencies, a cross-linking technique using an epoxy
compound as a fixative has recently been devel-
oped.12, 13 Furthermore, heparinization of biomate-
rials to enhance the antithrombogenicity is now
recognized as a decisive factor in the development
of antiadhesive membranes.14 The purpose of this
study was to evaluate host reaction to pericardial
substitute with and without incorporating slow hep-
arin release. In addition, two commercially available
synthetic pericardial substitutes (ePTFE and polyes-
ter polymeric patch) were used as controls.
Methods
Pericardium harvesting. Fresh porcine pericardia pro-
cured from a slaughterhouse were used as the raw mate-
rials. The procured porcine pericardia were transported in
cold physiologic saline solution. On return, the pericardia
were first gently rinsed with fresh saline solution to rid
them of excess blood on the tissue. Adherent fat was then
carefully trimmed from the pericardial surface. The max-
imum time period between retrieval and initiation of
tissue fixation was less than 10 hours.
Fixation process. For the epoxy-fixed pericardial
patches without ionically bound heparin, the porcine
pericardia were first fixed in an epoxy compound solution
(ethylene glycol diglycidyl ether, Denacol EX-810, Nagase
Chemicals, Ltd., Osaka, Japan) at room temperature for 6
days. The solution was buffered with sodium carbonate/
sodium bicarbonate (0.21/0.02 mol/L, pH 10.5). The
amount of solution used in fixation was approximately 200
ml for a 6 3 6 cm piece of pericardium. The fixed porcine
pericardia were subsequently sterilized with the same
epoxy compound solution (2%) at 37° C for 7 days.
For the epoxy-fixed pericardial patches with ionically
bound heparin, the fresh porcine pericardia were first
immersed in a 1% protamine sulfate solution for l hour.
The porcine pericardia were then fixed in the epoxy
compound solution as described at room temperature for
6 days. Finally, the fixed pericardia were heparinized in a
0.5% sodium heparin solution (from porcine intestinal
mucosa, Sigma Chemical Co., St. Louis, Mo.) at 37° C for
1 hour. The same sterilization procedure as used for the
epoxy-fixed patch without ionically bound heparin was
applied.
For the glutaraldehyde-fixed pericardial patches with-
out ionically bound heparin, the fresh porcine pericardia
Table I. Macroscopic assessment of the retrieved
pericardial substitutes
Pliability P0 Patch appeared soft and pliable
P1 Patch appeared less pliable without
thickening
P2 Patch appeared less pliable and
thickened
Adhesion M0 No adhesion
M1 Scanty adhesion, which can be
peeled off easily
M2 Mild adhesion; gentle dissection
required for separation
M3 Moderate adhesion; aggressive dis-
section required for separation
M4 Dense adhesion; sharp dissection
required for separation





E1 Trivial fibrotic layer; the underlying
structures were easily identifiable
E2 Dense fibrotic tissue layer; the rec-
ognition of underlying structures
was severely impeded
E3 Dense fibrotic tissue layer; the un-
derlying structures were not
identifiable





A1 Sparse focal neutrophils and
plasma cell infiltration
A2 Focal aggregates of neuro-
philes, plasma cells





C1 Sparse plasma cells and lym-
phocytes
C2 Focal aggregates of plasma
cells and lymphocytes
C3 Diffuse lymphocytic aggre-
gates in whole layers
C4 Diffuse lymphocytic aggre-
gates extending across the
patch
C5 Extensive lymphocytic aggre-
gates with necrotic cells
Fibrous reaction
(histologic findings)
F0 No fibrous reaction
F1 Minimal fibrous reaction
with trivial fibrin deposit
F2 Sparse focal fibrous connec-
tive tissue, hyalinization,
fibrin deposit
F3 A thin layer of fibrous con-
nective tissue, hyaliniza-
tion, fibrin deposit
F4 A thick layer of fibrous con-
nective tissue, hyaliniza-
tion, without evidence of
fibrous ingrowth
F5 Dense fibrous connective
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were first fixed in a 0.625% glutaraldehyde solution at
room temperature for 10 hours. The solution was buffered
with HEPES buffer (0.02 mol/L, pH 7.4). Subsequently,
the fixed pericardia were sterilized in a glutaraldehyde-
based sterilant in a phosphate buffer at 45° C for 2 days.
The heparinization process for the glutaraldehyde-fixed
pericardial patches with ionically bound heparin was
similar to that for their epoxy-fixed counterparts: the
impregnation of protamine and heparinization were per-
formed just before and after glutaraldehyde fixation,
respectively.
Composite membranes as pericardial substitutes. To
avoid biologic variation among these pericardial patches,
we used a composite membrane. Preparation of the
composite patches was completed by suturing these
patches with 6-0 polypropylene sutures in the following
order: (1) an epoxy-fixed patch with ionically bound
heparin, (2) a glutaraldehyde-fixed patch with ionically
bound heparin, (3) an ePTFE patch,* (4) a polyester
polymeric patch (Cooley low porosity polyester fabric,
Meadox Medicals, Inc., Oakland, N.J.), (5) an epoxy-fixed
patch without ionically bound heparin, and (6) a glutaral-
dehyde-fixed patch without ionically bound heparin. Each
individual patch was 3 cm in length and 1 cm in width,
which made a 3 cm 3 6 cm composite membrane. Care
was taken to ensure that the smooth side of this biologic
patch was in contact with the epicardial surface of the
recipient hearts.
Surgery. Ten recipient dogs weighing from 12 to 19 kg
(mean 13.6 kg) were used to assess the composite mem-
branes. An intravenous line, an arterial line in the femoral
artery, and an electrocardiographic monitor were estab-
lished. Anesthesia was induced via the external jugular
vein with 2.5% thiamylal sodium (Surital) at a dose of 17.5
mg/kg. Anesthesia was maintained in the operating room
with halothane and nitrous oxide in oxygen. Mechanical
ventilation was instituted with an approximate tidal vol-
ume set at 10 ml/kg body weight with 100% oxygen at a
rate of 8 to 14 cycles per minute. Anesthesia was main-
tained at stage III, planes 1 to 2, with a mixture of
halothane in oxygen. Ventilation rates were adjusted to
maintain arterial blood gases in the normal physiologic
range.
The heart was exposed via a left lateral thoracotomy
incision through the fourth intercostal space. A 2 3 5 cm
segment of the midportion of the pericardium was re-
moved and the composite patch was anchored to the
pericardial defect with 6-0 Prolene interrupted sutures
(Ethicon, Inc., Somerville, N.J.). Care was taken to avoid
contact with the epicardial surface of the heart. Prophy-
lactic antibiotics were given intravenously just before and
after the operation and were administered intramuscu-
larly for 5 days after the operation. Animal care was in
compliance with the “Principles of Laboratory Animal
Care” formulated by the National Society for Medical
* Gore-Tex surgical membrane, W. L. Gore & Associates, Inc.,
Flagstaff, Ariz,
Table III. Macroscopic evaluation of patch retrieved at 1, 2, 4, 8, or 12 weeks of implantation
Time
(wks)
Grades of pliability/adhesion/epicardial reaction: epicardial side of patch
Epoxy-fixed GA-fixed
ePTFE Polyesterw-H w/o-H w-H w/o-H
1 (n 5 1) P0M0E0 P0M0E0 P0M0E0 P0M0E0 P1M0E0 P1M0E0
2 (n 5 1) P0M0E0 P0M3E0 P0M0E0 P0M3E1 P1M0E1 P2M3E3
4 (n 5 1) P0M0E1 P1M3E1 P1M1E1 P1M2E1 P1M0E2 P2M4E3
8 (n 5 1) P1M2E1 P1M3E1 P1M2E1 P1M2E2 P1M0E2 P2M4E3
12 (n 5 6) P 5 0.8 6 0.2 P 5 1.3 6 0.2 P 5 1.0 6 0.4 P 5 1.4 6 0.6 P 5 1.0 6 0.0 P 5 2.0 6 0.0
M 5 2.8 6 0.9 M 5 4.5 6 0.5 M 5 3.2 6 0.4 M 5 4.3 6 0.5 M 5 0.0 6 0.0 M 5 5.0 6 0.0
E 5 1.0 6 0.0 E 5 1.6 6 0.4 E 5 1.0 6 0.0 E 5 1.8 6 0.4 E 5 2.6 6 0.0 E 5 3.0 6 0.0
w-H, With ionically bound heparin patch; w/o-H, without ionically bound heparin patch; GA-fixed, Glutaraldehyde-fixed patch; ePTFE, expanded
polytetrafluoroethylene patch; Polyester, polyester patch (Dacron); P, pliability; M, adhesion; E, epicardial reaction.
Table IV. Macroscopic evaluation of patch retrieved at 1, 2, 4, 8, or 12 weeks of implantation
Time (wk)
Grades of adhesion and pleural reaction: pleural side of patch
Epoxy-fixed GA-fixed
ePTFE Polyesterw-H w/o-H w-H w/o-H
1 (n 5 1) M0E0 M0E0 M0E0 M0E0 M0E0 M0E0
2 (n 5 1) M0E1 M3E1 M0E0 M3E1 M0E2 M3E2
4 (n 5 1) M1E1 M3E1 M2E0 M2E1 M0E2 M4E3
8 (n 5 1) M2E1 M3E2 M2E1 M3E1 M0E2 M5E3
12 (n 5 6) M 5 2.6 6 0.3 M 5 4.0 6 0.5 M 5 2.8 6 0.2 M 5 4.4 6 0.4 M 5 0.0 6 0.0 M 5 5.0 6 0.0
E 5 0.8 6 0.4 E 5 1.8 6 0.4 E 5 1.2 6 0.4 E 5 2.0 6 0.6 E 5 3.0 6 0.0 E 5 3.0 6 0.0
w-H, With ionically bound heparin patch; w/o-H, without ionically bound heparin patch; GA-fixed, glutaraldehyde-fixed patch; ePTFE, expanded
polytetrafluoroethylene patch; Polyester, polyester patch (Dacron); M, adhesion; E, pleural reaction.
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Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Labo-
ratory Animal Resources and published by the National
Institutes of Health (NIH Publication No. 86-23, revised
1985).
Pathologic examination. The implanted composite
membranes were retrieved at the end of 1 week (one
dog), 2 weeks (one dog), 4 weeks (one dog), 8 weeks
(one dog), and 12 weeks (six dogs) after the operation.
The en bloc heart, including pericardium and left lung,
was removed through a left-sided thoracotomy. The
retrieved composite membranes were then examined
and photographed. The development of adhesions and
the epicardial reaction were graded (Table I). Subse-
quently, the retrieved patches were fixed in 10% phos-
phate-buffered formalin for at least 3 days. Histologic
specimens of the patches, suture lines, and epicardia
were obtained. All specimens for histologic examina-
tion, including the samples taken after harvesting, were
embedded in paraffin, sectioned at 5 mm, and stained
Fig. 1. The epoxy-fixed patch with ionically bound heparin retrieved 12 weeks after implantation; stain:
hematoxylin-eosin. Left, Light micrograph showed focal fibrosis, a scattering of hemorrhagic infiltrations,
and occasional lymphocytes and plasma cells. The thin layer of fibrous tissue (F) covered the intact patch
(P) and the myocardium (C) (320). Right, The pleural side of the patch showed fibrous reactive zone (F)
over the lung. The epicardial side (epi) of the patch was clear with minimal epicardial fibrous reaction (F)
(3l00).
Table V. Microscopic evaluation of patch retrieved at 1, 2, 4, 8, or 12 weeks of implantation
Time (wk)
Grades of inflammatory and fibrous reaction: epicardial side of patch
Epoxy-fixed GA-fixed
ePTFE Polyesterw-H w/o-H w-H w/o-H
1 (n 5 1) A1C0F0 A2C0F0 A2C0F0 A2C0F0 A3C0F0 A3C0F0
2 (n 5 1) A1C0F1 A3C0F1 A2C0F0 A3C0F1 A3C0F1 A4C0F3
4 (n 5 1) A1C1F3 A2C2F2 A1C1F0 A1C1F2 A3C1F3 A3C4F3
8 (n 5 1) A1C1F3 A2C2F4 A1C2F2 A1C2F4 A2C2F4 A2C4F5
12 (n 5 6) A 5 1.0 6 0.2 A 5 2.3 6 0.4 A 5 1.2 6 0.3 A 5 2.6 6 0.7 A 5 1.6 6 0.3 A 5 2.0 6 0.2
C 5 2.0 6 0.0 C 5 2.2 6 0.3 C 5 2.2 6 0.4 C 5 2.2 6 0.4 C 5 2.2 6 0.4 C 5 4.2 6 0.4
F 5 2.8 6 0.3 F 5 3.8 6 0.2 F 5 3.0 6 0.2 F 5 4.0 6 0.0 F 5 4.0 6 0.0 F 5 5.0 6 0.0
w-H, With ionically bound heparin patch; w/o-H, without ionically bound heparin patch; GA-fixed, glutaraldehyde-fixed patch; ePTFE, expanded
polytetrafluoroethylene patch; Polyester, polyester patch (Dacron); A, acute inflammatory reaction; C, chronic inflammatory reaction; F, fibrous reaction
(histology).
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with hematoxylin-eosin. All biologic patches were
stained with van Gieson technique additionally to dem-
onstrate the collagen component. A system of assessing
the microscopic status of the individual patches by
assigning them arbitrary scores was devised and is
described in Table II.
Results
All the animals survived implantation and were
evaluated as scheduled. From the sequential ob-
servation of the specimens, the epicardial and
pleural reactions to the patch could be classified
Fig. 2. The epoxy-fixed patch without ionically bound heparin retrieved 12 weeks after implantation; stain:
hematoxylin-eosin. Left, Cross section on the surface of the heart. Light micrograph showed dense
collagenous fibrosa (F) with strongly folded surface. The epicardial inflammatory zone (2) of the patch (P)
was covered with fibrous tissue (F) with edematous reaction (E) (320). Top right, The inflammatory zone
of pleural side (1) of the patch showed dense fibrous tissue. Light micrograph showed focal fibrosis,
diffused infiltration of lymphocytes, and plasma cells through epicardial layers (2) (3100). Bottom right,
Patch appeared soft and pliable. The epicardial fibrosis (F) could be peeled off easily (3200). CA, Coronary
artery; S, suture.
Table VI. Microscopic evaluation of patch retrieved at 1, 2, 4, 8, or 12 weeks of implantation
Time (wk)
Grades of inflammatory and fibrous reaction: Pleural side of patch
Epoxy-fixed GA-fixed
ePTFE Polyesterw-H w/o-H w-H w/o-H
1 (n 5 1) A1C0F0 A2C0F0 A2C0F0 A2C0F0 A3C0F0 A3C0F0
2 (n 5 1) A2C0F2 A3C1F3 A3C0F3 A3C1F2 A3C1F4 A3C2F4
4 (n 5 1) A1C1F1 A3C4F3 A2C2F3 A2C4F2 A2C2F4 A2C5F5
8 (n 5 1) A1C2F4 A2C3F4 A1C3F2 A2C3F3 A2C2F4 A2C5F5
12 (n 5 6) A 5 1.2 6 0.1 A 5 1.6 6 0.4 A 5 1.0 6 0.3 A 5 1.4 6 0.2 A 5 2.6 6 0.4 A 5 2.2 6 0.2
C 5 2.2 6 0.4 C 5 3.2 6 0.2 C 5 2.6 6 0.4 C 5 3.4 6 0.4 C 5 2.2 6 0.3 C 5 5.0 6 0.0
F 5 2.6 6 0.6 F 5 4.0 6 0.0 F 5 2.5 6 0.2 F 5 4.0 6 0.0 F 5 3.4 6 0.0 F 5 5.0 6 0.0
w-H, With ionically bound heparin patch; w/o-H, without ionically bound heparin patch; GA-fixed, glutaraldehyde-fixed patch; ePTFE, expanded
polytetrafluoroethylene patch; Polyester, polyester patch (Dacron); A, acute inflammatory reaction; C, chronic inflammatory reaction; F, fibrous reaction.
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macroscopically with regard to pliability of the
patch, adhesions to the epicardium, and epicardial
fibrous reaction (Tables III and IV). Microscopic
evaluation included acute and chronic active in-
flammatory reaction and fibrous reaction (Tables
V and VI).
Macroscopic findings. The synthetic patches
were thicker and less pliable than the porcine peri-
cardial patches. Additionally, the synthetic patches
had a more notable adhesion and fibrosis than the
biologic patches. The epicardial surface beneath all
synthetic patches became thickened by a dense layer
of fibrotic tissue by 12 weeks (Table III). The
recognition of the coronary artery and other under-
lying structures beneath synthetic patches was
greatly impeded by fibrotic ingrowth tissue. In this
study, the smooth side of the biologic patch was in
contact with the epicardial surface of the recipient
heart. Generally, for all the porcine pericardial
patches, the adhesion on the rough surface (pleural
Fig. 3. The glutaraldehyde-fixed patch with ionically bound heparin retrieved 12 weeks after implantation;
stain: van Gieson stain. Mild fibrosis was demonstrated with dense collagenous fibrosa (F) on the epicardial
surface (epi) of the patch (P). Right, 320; left, 3100. C, Myocardium; L, lung.
Fig. 4. The glutaraldehyde-fixed patch without ionically bound heparin retrieved 12 weeks after implan-
tation; stain: van Gieson stain. Compared with the heparinized patch in Fig. 3, both the inflammatory (I)
and fibrous reaction (F) were more severe in the nonheparinized patch. Left, 320; right, 3100.
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Fig. 5. An ePTFE patch retrieved 12 weeks after the operation; stain: hematoxylin-eosin. Left, On gross
examination, dense adhesions with a thick layer of fibrous tissue (F) were present in both sides of the patch
(P). The ePTFE patch did not appear shrunken or thickened. Top right, The pleural (1) and epicardial
surfaces (2) were thickened. The ePTFE patch itself was intact without fibrous ingrowth. The presence of
a tissue-free space (*) around the ePTFE patch (P) could be identified (320). Bottom right, Histologically,
the patch was composed of hyaline and dense fibrous connective tissue. The underlying epicardium (epi)
was covered by a dense layer of fibrotic tissue (F) beneath the ePTFE patch (3100).
Fig. 6. A polyester patch (Dacron) retrieved 12 weeks after implantation; stain: hematoxylin-eosin. Left,
On gross examination, dense adhesion with a thick layer of fibrous tissue (F) was present in both sides of
the Dacron patch (D) (320). Top right, The Dacron (D) itself appeared shrunken and thickened with a
dense fibrous ingrowth (F). Dense adhesions were present between the inflammatory zone of pleural (7)
and epicardial side (7) (3100). Bottom right, Severe fibrosis was identified (3200). L, Lung; C,
myocardium; Epi, epicardial fibrosis.
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side) was more severe than that observed on the
smooth surface (epicardial side) (Table IV). In all
groups, no differences in the formation of adhesions
were noted between interrupted sutures. The adhe-
sions were somewhat firmer at the level of suture
lines.
Microscopic findings. The acute inflammatory
reaction was chiefly noted in the first several weeks.
This reaction consisted of ecchymosis with neutro-
phil infiltration into the epicardium as a sign of
postoperative mechanical stimulation from a foreign
body. The degree of acute inflammatory reaction
decreased after 2 weeks of implantation. The
chronic active inflammatory reaction consisted of a
large amount of lymphocyte aggregation, histio-
cytes, macrophages, giant cells, and an association
with necrotic cells. The fibroblast reaction was rep-
resented as focal fibrosis, hyalinization, fibrin de-
posit, and dense fibrous connective tissue. The se-
verity of mononuclear lymphocyte infiltration with
fibrosis as a sign of chronic active inflammatory
reaction gradually increased after 4 weeks of im-
plantation (Tables V and VI). Compatible with
macroscopic findings, the inflammatory and fibrous
reaction on the rough surface of biologic patch
(pleural side) was more severe than that observed
on the smooth surface (epicardial side).
Epoxy-fixed pericardial substitutes. On gross ex-
amination, all epoxy-fixed patches appeared soft and
pliable. The patches with heparin caused minimal to
mild acute and chronic inflammatory reaction be-
tween the patch and the epicardial surface before 12
weeks. Histologic studies showed only sparse neu-
trophils and plasma cell infiltration. Also, on gross
examination, the external (pulmonic) layer of the
patch showed trivial fibrin deposits. The fibrous
reaction was minimal, and only scanty adhesion with
fibrin deposits to the epicardium and suture lines
was observed before 12 weeks. However, the adhe-
sion was aggravated in those patches retrieved at 12
weeks. Histologic studies showed a thin fibrous
tissue layer. There were mild chronic inflammatory
reactions in the patches with heparin at 12 weeks
after implantation (Fig. 1). Observations in the
patches without heparin were similar to those in the
heparin-bound patches, although the inflammatory
reaction and epicardial adhesion were more severe
(Fig. 2).
Glutaraldehyde-fixed pericardial substitutes.
Observations in the glutaraldehyde-fixed pericardial
substitutes were similar to those in their epoxy-fixed
counterparts. Histologic studies showed mildly
acute and chronic inflammatory reactions with focal
fibrosis, a scattering of hemorrhagic infiltrates, and
occasional inflammatory cells in those heparin-
bound patches (Fig. 3). The epicardial layer of the
patch showed fibrin deposits, but they could be
detached easily by finger dissection. For the patches
without ionically bound heparin, adhesions had be-
come severe at 12 weeks (Fig. 4). On the other hand,
only moderate adhesions were observed for the
patches with ionically bound heparin.
ePTFE pericardial substitutes. The ePTFE patch
was thicker and less pliable than the porcine peri-
cardial patches. It was adherent to the epicardial
surface of the heart in all dogs at 12 weeks. On gross
examination, a thick layer of fibrous tissue covering
the intact patch was noted (Fig. 5, left). Dense
adhesions were present between the pericardium
and the myocardium. The presence of a tissue-free
space around the synthetic patch can be identified in
all specimen (Fig. 5, top left and bottom left). How-
ever, beneath the synthetic patch the underlying
epicardium became covered by a dense layer of
fibrotic tissue. The epicardial surface thickened.
Recognition of the coronary artery was greatly
impeded by this fibrotic tissue, which was very
difficult to separate from the underlying myocar-
dium and vessels. No ePTFE patches appeared
shrunken or thickened.
Severe epicardial inflammatory reactions were
present in all the test samples. At 2 weeks after
implantation, moderate acute inflammatory changes
with mild adhesions were observed for the ePTFE
patches. These had progressed to severe adhesions
with chronic active inflammatory changes at 12
weeks. The pulmonary side had a more obvious
inflammatory reaction than the cardiac side in each
observation. The fibrotic tissue became thicker with
time. Histologically, this was composed of hyaline
and dense fibrous connective tissue and showed no
evidence of fibrous ingrowth.
Polyester pericardial substitutes. The polyester
patch (Dacron) brought on the most severe inflam-
matory reaction and fibrosis between the pleura and
epicardium. Diffuse fibrosis was present in all Da-
cron patches. On gross examination all patches
appeared shrunken and thickened (Fig. 6, left). Two
weeks after implantation, moderate adhesions were
observed for these polyester patches. Severe adhe-
sions were found at 4 weeks. These structural
changes occurred on both surfaces of the patch
(Tables IV and V). This layer could not be dissected
away from the epicardium because of its thickness
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and adherence. There was no tissue-free space
around the Dacron patch. The underlying structures
were not identifiable. Histologic examination
showed growth of dense fibrous connective tissue.
The Dacron fabric itself showed a dense fibrous
ingrowth of native collagen between the fiber of the
Dacron patch at the sites of contact with the epicar-
dial wall. The epicardial surface showed severe
active chronic inflammation at 12 weeks (Fig. 6, top
left and bottom left), which was localized directly
below the patch.
Discussion
Reoperation is a risk predominantly because
fibrosis and scarring increase the danger of injury
to the heart, great vessels, or grafts during a
repeat sternotomy.15 Reoperations are prolonged
by the takedown of adhesions and are associated
with increased operative bleeding and complica-
tions. The presence of epicardial fibrosis obscures
the underlying anatomic structures. This is partic-
ularly important in patients undergoing repeat
coronary artery revascularization, because the
identification of the coronary arteries is tedious
and hazardous.
Research on heterologous pericardial substi-
tutes had focused on the glutaraldehyde-treated
pericardium. Meus and coworkers5 reported that
glutaraldehyde-treated biologic patches were ex-
cellent substitutes and had better antithromboge-
nicity than synthetic pericardial substitutes. Using
a growing rat model, Okoshi’s group16 reported
that the epoxy-fixed collagen gel disks implanted
subcutaneously showed remarkably less calcium
deposition than their glutaraldehyde-fixed coun-
terparts. To overcome the thrombogenic problem
commonly observed in the prosthetic vascular
grafts, Noishiki and Miyata14 developed a simple
method to ionically bind heparin to the biologic
arteries fixed with glutaraldehyde or epoxy com-
pounds. In their animal studies, they found that
the heparinized vascular grafts were significantly
superior in antithrombogenicity to their nonhepa-
rinized counterparts. Although heparinized bio-
materials, such as cardiac valve substitutes,16, 17
vascular grafts, or conduits,18, 19 have been
throughly examined, no reports on these bioma-
terials in use as pericardial substitutes have been
published. Inspired by these encouraging results,
we undertook the development of a pericardial
patch fixed in different compounds with or with-
out ionically bound heparin.
In the development of biologic pericardial sub-
stitutes,12 it was discovered that the porcine peri-
cardia fixed with an epoxy compound were softer
and more pliable that those preserved with glu-
taraldehyde. Additionally, the pericardia cross-
linked with polyepoxy compound appeared whiter
and more appealing than their glutaraldehyde
counterparts. The superiority in pliability of the
pericardia fixed with epoxy compound might be
due to the flexible ether joint in the epoxy com-
pound.16 The experimental results of porcine peri-
cardia with heparinization used to close pericar-
dial defects in dogs are very encouraging. The
porcine patches with ionically bound heparin were
found to have significantly less adhesion forma-
tion than those without ionically bound heparin at
each time period assessed. Although minimal
adhesions developed in heparinized patches,
these were easily dissected. At retrieval, under
microscopic observation, minimal chronic active
inflammatory changes were observed in the poly-
epoxy compound– cross-linked patches in compar-
ison with their glutaraldehyde counterparts. Both
ePTFE and polyester polymeric patches caused
severe epicardial fibrotic adhesion with chronic
active inflammatory reactions.
Overall, this observation highlighted the fact that
pericardial substitutes bonded with heparin may
reduce inflammatory reaction and fibrous forma-
tion. However, it is possible that the experimental
findings might not be completely reproducible clin-
ically, because the operations performed in this
study did not damage the epicardium, cardiopulmo-
nary bypass was not performed, and postoperative
bleeding was minimal. The actual clinical condition
might be quite different from the study design.
Another unsolved problem is that the reduction of
heparin on the surface of biologic tissue can reduce
its antiadhesive capability. Our results suggested
that a small amount of heparin was continuously
released over a long period of time. Noishiki and
Miyata14 showed that about 45% of the initial
heparin content was released after 1 month’s rinsing
in vitro, 63% after 2 months, and 76% after 3
months. In this experiment, the adhesion and fibro-
sis in patches with heparin are progressively in-
creased at 12 weeks. The release rate of heparin in
the pericardial substitutes with ionically bound hep-
arin was unknown. Experiments in vitro with a
longer follow-up are underway to clarify the release
rate of the ionically bound heparin in pericardial
substitutes.
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